Jubilant Pharmova Falls 3.22%: Downgrade and Technical Shift Weigh on Stock
2026-11-21 17:04:33Key Events This Week 16 Nov: Stock opens at Rs.960.95, down 0.43% 19 Nov: Downgrade to Sell rating announced 20 Nov: Technical momentum shift confirmed, stock closes at Rs.934.05 20 Nov: Week closes with a 3.22% decline vs Sensex +1.55% Week OpenRs.965.10 Week CloseRs.934.05<div class="st...
Read More
Jubilant Pharmova Ltd Downgraded to Sell Amid Weak Financials and Technicals
2026-11-20 08:05:28Jubilant Pharmova Ltd has seen its investment rating downgraded from Hold to Sell as of 19 Nov 2026, reflecting deteriorating financial performance, subdued technical indicators, and disappointing valuation metrics. The pharmaceutical company’s recent quarterly results and long-term trends have raised concerns among analysts, prompting a reassessment of its growth prospects and market positioning.
Read More
Jubilant Pharmova Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals
2026-11-20 08:01:55Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish trend to a sideways movement. This change is underscored by a complex interplay of technical indicators, including MACD, RSI, Bollinger Bands, and moving averages, which collectively signal a cautious outlook for the pharmaceutical and biotechnology company amid a challenging market environment.
Read More
Jubilant Pharmova Ltd is Rated Hold by MarketsMOJO
2026-11-09 10:10:40Jubilant Pharmova Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with the latest insights into its performance and outlook.
Read MoreJubilant Pharmova’s 1.40% Weekly Decline Amid Mixed Technical Signals and Downgrade
2026-10-31 17:02:34Key Events This Week 26 Oct: Stock opens at Rs.938.20 with mild positive movement 27 Oct: Downgrade to Sell rating announced; stock rises 1.87% to Rs.955.75 28 Oct: Technical momentum shifts to mildly bullish; stock retreats 1.09% to Rs.945.35 29 Oct: Technical indicators signal sideways trend; stock closes at Rs.942.40 (-0.31%) 30 Oct: Stock declines sharply by 1.88% to Rs.924.70, closing the week lower <div c...
Read More
Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-10-29 08:01:23Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a recent downgrade from a Sell to a Hold rating by MarketsMOJO on 26 Oct 2026, the stock’s mixed technical indicators suggest a complex outlook for investors navigating the Pharmaceuticals & Biotechnology sector.
Read More
Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-28 08:02:51Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance on daily moving averages, despite mixed signals from key technical indicators such as MACD, RSI, and Bollinger Bands. This nuanced change reflects a complex interplay of short-term optimism against longer-term caution within the Pharmaceuticals & Biotechnology sector.
Read More
Jubilant Pharmova Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-10-27 08:03:03Jubilant Pharmova Ltd has experienced a notable shift in its technical momentum, transitioning from a mildly bullish stance to a sideways trend. Despite a marginal day change of 0.04% with the stock closing at ₹938.20, a detailed analysis of key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages reveals a complex picture for investors navigating the Pharmaceuticals & Biotechnology sector.
Read More
Jubilant Pharmova Ltd is Rated Hold
2026-10-25 10:10:03Jubilant Pharmova Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 October 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
18-Nov-2026 | Source : BSEDisclosure under regulation 30 and 51 of SEBI (LODR) 2015 for the Grant of RSUs.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
16-Nov-2026 | Source : BSEInvestor Meet Outcome
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Nov-2026 | Source : BSENewspaper Publication
Corporate Actions
No Upcoming Board Meetings
Jubilant Pharmova Ltd has declared 500% dividend, ex-date: 24 Jul 26
Jubilant Pharmova Ltd has announced 1:5 stock split, ex-date: 17 Mar 06
No Bonus history available
No Rights history available